Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692371016 | Ursodiol 50 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3692373018 | Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3692374012 | Ursodeoxycholic acid 50 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4703081000052110 | ursodeoxicholsyra 50 milligram/milliliter, oral suspension | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Ursodeoxycholic acid-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Ursodeoxycholic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Ursodeoxycholic acid (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | har täljarvärde för koncentrationsstyrka | 50 | false | Inferred relationship | Some | 1 | |
| Product containing precisely ursodeoxycholic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Ursodeoxycholic acid only product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR